DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Dexamethasone (Dexamethasone) - Diarrhoea - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Diarrhoea (139)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Dexamethasone where reactions include diarrhoea. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 139   Next >>

Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-08-22

Patient:

Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Coagulopathy, Hypoglycaemia, Hypocalcaemia, Hypoxia, Hiccups, Alanine Aminotransferase Abnormal, Pneumonitis, Cough, Pain in Extremity, Hypotension, Hyperglycaemia, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin HCL
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate Sodium
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Vancomycin; Posaconazole; Voriconazole; Levofloxacin



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-08-20

Patient:

Reactions: Abdominal Pain, Thrombosis, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypokalaemia, Blood Bilirubin Abnormal, Hiccups, Pleural Effusion, Hypoxia, Hypocalcaemia, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Decreased Appetite, Pain in Extremity, Hypotension, Hyperglycaemia, Gamma-Glutamyltransferase Abnormal, Hyponatraemia, External Ear Pain, Hypercalcaemia, Haematotoxicity, Hypophosphataemia, Diarrhoea, Dehydration, Hypoalbuminaemia, Lower Gastrointestinal Haemorrhage, Hypertension, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Levofloxacin; Voriconazole; Posaconazole; Vancomycin



Possible Dexamethasone side effects in

Reported by a physician from France on 2012-08-15

Patient:

Reactions: Diarrhoea

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1672 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-06-08

Dexamethasone
    Dosage: 20 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-06-08

Velcade
    Dosage: 2899 unk, unk
    Indication: Multiple Myeloma
    Start date: 2012-06-08

Other drugs received by patient: Valaciclovir; Esomeprazole; Atovaquone; Phenoxymethylpenicillin; Sodium Bicarbonate; Allopurinol



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-08-14

Patient:

Reactions: Thrombosis, Abdominal Pain, Hyperkalaemia, Hypoglycaemia, Coagulopathy, Hypoxia, Hypocalcaemia, Hiccups, Alanine Aminotransferase Abnormal, Cough, Pneumonitis, Pain in Extremity, Hyperglycaemia, Hypotension, External Ear Pain, Haematotoxicity, Dehydration, Lower Gastrointestinal Haemorrhage, Hypofibrinogenaemia, Aspartate Aminotransferase Abnormal, Hypokalaemia, Neuropathy Peripheral, Blood Bilirubin Abnormal, Pleural Effusion, Decreased Appetite, Hyponatraemia, Gamma-Glutamyltransferase Abnormal, Hypercalcaemia, Hypophosphataemia, Diarrhoea, Hypoalbuminaemia, Hypertension, Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Asparaginase
    Dosage: 2500 units/m2/dose as 4 weekly doses
    Indication: Acute Lymphocytic Leukaemia

Bortezomib
    Dosage: 1.3 mg/sq.m/dose on days 1, 4, 8 and 11 combined with vxld
    Indication: Acute Lymphocytic Leukaemia

Cytarabine
    Dosage: on day 1 for all patients and on days 8, 15, 22 for cns invlovment
    Indication: Acute Lymphocytic Leukaemia

Dexamethasone
    Dosage: 10 mg/m2/day divided in to 2 doses for 14 consecutive days
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia

Doxorubicin Hydrochloride
    Dosage: given over 15-30 minutes on day 1
    Indication: Acute Lymphocytic Leukaemia

Hydrocortisone
    Dosage: on days 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 1 dose on day 15 for no cns involvement and on days 8, 15, 22 for cns involvement
    Indication: Acute Lymphocytic Leukaemia

Vincristine
    Dosage: 1.5 mg/m2/dose, max. 2 mg, by push on days 1, 8, 15 and 22
    Indication: Acute Lymphocytic Leukaemia

Other drugs received by patient: Levofloxacin; Vancomycin; Posaconazole; Voriconazole



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14

Patient:

Reactions: Vomiting, Syncope, Diarrhoea, Nausea, Asthenia, Epistaxis, Haematemesis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: day 22
    Administration route: Oral

Dexamethasone
    Dosage: day 1
    Administration route: Oral
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: day 8
    Administration route: Oral

Dexamethasone
    Dosage: day 15
    Administration route: Oral

Lenalidomide
    Dosage: day 1-21
    Administration route: Oral
    Indication: Multiple Myeloma

Vorinostat
    Dosage: days 1-7
    Administration route: Oral
    Indication: Multiple Myeloma

Vorinostat
    Dosage: days 15-21
    Administration route: Oral

Other drugs received by patient: Aspirin



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06

Patient:

Reactions: Anaphylactic Reaction, Pyrexia, Headache, Hyperhidrosis, Oedema Peripheral, Cough, Muscle Spasms, Diverticular Perforation, Back Pain, Pneumonia, Anaemia, Insomnia, Neutropenia, Stridor, Chills, Constipation, Hypokalaemia, Disease Progression, Fatigue, Dizziness, Thrombocytopenia, Enteritis, Dyspnoea, Nausea, Lymphopenia, Atrial Fibrillation, Febrile Neutropenia, Rash, Lung Disorder, Diarrhoea, Arthralgia, Sepsis, Bradycardia, Asthenia

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Elotuzumab
    Dosage: 5, 10 and 20 mg/kg
    Indication: Multiple Myeloma

Elotuzumab
    Dosage: 5, 10 and 20 mg/kg

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in

Reported by a physician from Finland on 2012-08-06

Patient:

Reactions: Diarrhoea, Orthostatic Hypotension, Thrombotic Thrombocytopenic Purpura, Haemolytic Uraemic Syndrome

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 20 mg, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 mg/m2, cyclic
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.0 mg/m2, cyclic



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-08-02

Patient:

Reactions: Electrocardiogram QT Prolonged, Hypokalaemia, Hypocalcaemia, Thrombocytopenia, Lethargy, Pneumonia, Nausea, Hyperglycaemia, Atrial Fibrillation, Febrile Neutropenia, Arthralgia, Diarrhoea, Dehydration, Neutropenia, Asthenia, Leukopenia

Drug(s) suspected as cause:
Dexamethasone
    Indication: Multiple Myeloma

Lenalidomide
    Dosage: 5 or 10mg (daily,days 1-21 of ea cycle)
    Administration route: Oral
    Indication: Multiple Myeloma

Treanda
    Dosage: 75 or 100mg/m2 (day 1 and 2 of ea cycle)
    Indication: Multiple Myeloma

Other drugs received by patient: Gastroprotectant; Acetylsalicylic Acid SRT



Possible Dexamethasone side effects in

Reported by a physician from Netherlands on 2012-07-30

Patient:

Reactions: Diarrhoea, Pyrexia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1000 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-04
    End date: 2012-05-11

Dexamethasone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-04
    End date: 2012-05-15

Velcade
    Dosage: 2.6 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-04
    End date: 2012-05-14



Possible Dexamethasone side effects in 70 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-27

Patient: 70 year old female

Reactions: Diarrhoea, Insomnia

Drug(s) suspected as cause:
Dexamethasone

Revlimid
    Indication: Multiple Myeloma
    Start date: 2011-02-01
    End date: 2012-07-26



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23

Patient:

Reactions: Electrocardiogram QT Prolonged, Hypokalaemia, Hypocalcaemia, Thrombocytopenia, Lethargy, Pneumonia, Nausea, Hyperglycaemia, Febrile Neutropenia, Atrial Fibrillation, Arthralgia, Diarrhoea, Dehydration, Neutropenia, Asthenia, Leukopenia

Drug(s) suspected as cause:
Bendamustine Hydrochloride
    Dosage: 75 or 100mg/m2
    Indication: Multiple Myeloma

Dexamethasone
    Indication: Multiple Myeloma

Revlimid
    Dosage: 5 or 10mg
    Administration route: Oral
    Indication: Multiple Myeloma

Other drugs received by patient: Gastroprotectant; Aspirin



Possible Dexamethasone side effects in 72 year old female

Reported by a health professional (non-physician/pharmacist) from Austria on 2012-07-20

Patient: 72 year old female

Reactions: Bone Pain, Polyuria, Peripheral Sensory Neuropathy, Constipation, Disease Progression, Oedema Peripheral, Dermatitis Bullous, Muscle Spasms, Decreased Appetite, Spinal Fracture, Nausea, Anaemia, Muscular Weakness, Micturition Urgency, Haemoglobin Decreased, Diarrhoea, Visual Impairment, Neutropenia, Hypertension, Herpes Virus Infection, Leukopenia

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg
    Administration route: Oral
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 12 mg
    Administration route: Oral
    End date: 2010-03-01

Dexamethasone
    Dosage: 40 mg
    Administration route: Oral

Dexamethasone
    Dosage: 20 mg
    Administration route: Oral

Lenalidomide
    Dosage: 25 mg
    Indication: Multiple Myeloma

Lenalidomide
    Dosage: 15 mg

Lenalidomide
    Dosage: 10 mg

Lenalidomide
    Dosage: 5 mg
    End date: 2010-03-01

Pamidronate Disodium
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-18

Patient:

Reactions: Pneumonia, Nausea, Lymphopenia, Hyperglycaemia, Anaemia, Febrile Neutropenia, Constipation, Renal Failure, Neuropathy Peripheral, Fatigue, Diarrhoea, Embolism, Neutropenia, Thrombocytopenia, Deep Vein Thrombosis

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 500 milligram/sq. meter
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: 40 milligram
    Indication: Multiple Myeloma

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma

Revlimid
    Dosage: 15 milligram
    Administration route: Oral

Velcade
    Dosage: 1.3 milligram/sq. meter
    Indication: Multiple Myeloma

Velcade
    Dosage: 1.3 milligram/sq. meter



Possible Dexamethasone side effects in 55 year old male

Reported by a physician from United Kingdom on 2012-07-16

Patient: 55 year old male, weighing 71.4 kg (157.1 pounds)

Reactions: Drug Ineffective, Diarrhoea, Multiple Myeloma

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 160 mg, qmo
    Administration route: Oral
    Start date: 2010-10-18
    End date: 2010-11-09

Dexamethasone
    Dosage: 160 mg, qmo
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Doxorubicin HCL
    Dosage: 64 mg, qmo
    Start date: 2010-10-18
    End date: 2010-11-09

Doxorubicin HCL
    Dosage: 64 mg/h, qmo
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Velcade
    Start date: 2010-10-18
    End date: 2010-11-10

Velcade
    Indication: Multiple Myeloma
    Start date: 2010-09-27

Other drugs received by patient: Amoxicillin; Gabapentin; Acetaminophen; Furosemide; Enoxaparin Sodium



Possible Dexamethasone side effects in

Reported by a individual with unspecified qualification from United Kingdom on 2012-07-13

Patient:

Reactions: Diarrhoea, Multiple Myeloma

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 160 mg, unk
    Administration route: Oral
    Start date: 2010-10-18
    End date: 2010-11-09

Dexamethasone
    Dosage: 160 mg, unk
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2010-09-27
    End date: 2010-10-17

Doxorubicin HCL
    Dosage: 64 mg, unknown
    Start date: 2010-10-18
    End date: 2010-11-09

Doxorubicin HCL
    Dosage: 64 mg, unknown
    Indication: Polyuria
    Start date: 2010-09-27
    End date: 2010-10-17

Velcade
    Dosage: 2.4 mg/m2, unknown
    Indication: Anti-Infective Therapy
    Start date: 2010-09-27

Velcade
    Dosage: 2.4 mg/m2, unknown
    Start date: 2010-10-18
    End date: 2010-11-09

Other drugs received by patient: Acetaminophen; MK-0805; Gabapentin; Amoxicillin; MK-0805; Enoxaparin Sodium; Bebetina



Possible Dexamethasone side effects in

Reported by a physician from Austria on 2012-07-12

Patient:

Reactions: Bone Pain, Polyuria, Multiple Myeloma, Peripheral Sensory Neuropathy, Constipation, Oedema Peripheral, Dermatitis Bullous, Muscle Spasms, Decreased Appetite, Nausea, Anaemia, Muscular Weakness, Lumbar Vertebral Fracture, Micturition Urgency, Diarrhoea, Visual Impairment, Neutropenia, Hypertension, Herpes Virus Infection, Leukopenia

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 40 mg, on days 1-4, 9-12, and 17-20 for the first four cycles and on days 1-4 thereafter
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2004-06-01
    End date: 2005-10-01

Dexamethasone
    Dosage: 20 mg on days 1-4 of each cycle
    Administration route: Oral

Dexamethasone
    Dosage: 12 mg on days 1-4 of each cycle
    Administration route: Oral
    End date: 2010-03-01

Lenalidomide
    Dosage: 25 mg, on days 1-21 of each 28-day cycle
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2005-11-01

Lenalidomide
    Dosage: 15 mg daily on days 1-21
    Administration route: Oral
    End date: 2010-03-01

Lenalidomide
    Dosage: 10 mg, daily on days 1-21
    Administration route: Oral

Lenalidomide
    Dosage: 5 mg, daily on days 1-21
    Administration route: Oral
    End date: 2010-03-01

Other drugs received by patient: Pamidronate Disodium



Possible Dexamethasone side effects in

Reported by a physician from Netherlands on 2012-07-12

Patient:

Reactions: Diarrhoea, Pyrexia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1000 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-04
    End date: 2012-05-11

Dexamethasone
    Dosage: 40 mg, unk
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-05-04
    End date: 2012-05-15

Velcade
    Dosage: 2.6 mg, unk
    Indication: Multiple Myeloma
    Start date: 2012-05-04
    End date: 2012-05-14



Possible Dexamethasone side effects in 62 year old male

Reported by a physician from United Kingdom on 2012-07-03

Patient: 62 year old male

Reactions: Fatigue, Diarrhoea, Nausea, Pulmonary Embolism, Electrolyte Imbalance, Lower Respiratory Tract Infection

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 160 mg;;po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-01-05
    End date: 2010-02-26

Velcade
    Dosage: 2.5 mg;;iv, 1.3 mg;;iv
    Indication: Multiple Myeloma
    Start date: 2010-03-29
    End date: 2010-03-29

Velcade
    Dosage: 2.5 mg;;iv, 1.3 mg;;iv
    Indication: Multiple Myeloma
    Start date: 2010-01-05

Other drugs received by patient: Acyclovir; Fluconazole; Dexamethasone; Fentanyl; Furosemide; Lansoprazole; Melphalan Hydrochloride; Vincristine; Doxorubicin HCL; Metformin Hydrochloride; Pioglitazone; Cyclophosphamide; Thalidomide; Glimepiride



Possible Dexamethasone side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-03

Patient: 55 year old male

Reactions: Diarrhoea, Neoplasm Progression, Multiple Myeloma

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 160 mg; ;po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Dexamethasone
    Dosage: 160 mg; ;po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-10-18
    End date: 2010-11-09

Doxorubicin HCL
    Dosage: 64 mg; iv
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Doxorubicin HCL
    Dosage: 64 mg; iv
    Indication: Multiple Myeloma
    Start date: 2010-10-10
    End date: 2010-11-09

Velcade
    Dosage: 2.4 mg/m2; ;iv
    Indication: Multiple Myeloma
    Start date: 2010-09-27

Velcade
    Dosage: 2.4 mg/m2; ;iv
    Indication: Multiple Myeloma
    Start date: 2010-10-18
    End date: 2010-11-09

Other drugs received by patient: Amoxicillin; Gabapentin; Furosemide; Acetaminophen; Enoxaparin Sodium; Furosemide



Possible Dexamethasone side effects in

Reported by a physician from Serbia on 2012-06-29

Patient:

Reactions: Malaise, Hyperpyrexia, Hypoproteinaemia, Diarrhoea, Hypotension, Pseudomembranous Colitis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Adriablastin
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-11-23
    End date: 2012-03-01

Amikacin

Dexamethasone
    Dosage: unk
    Indication: Multiple Myeloma
    Start date: 2011-11-23
    End date: 2012-03-01

Meropenem

Vancomycin

Velcade
    Dosage: 1.3 mg, unk
    Indication: Multiple Myeloma
    End date: 2012-03-01

Other drugs received by patient: Diunorm; Losartan Potassium; Norvasc; Pantoprazole



Possible Dexamethasone side effects in 55 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-29

Patient: 55 year old male, weighing 71.4 kg (157.1 pounds)

Reactions: Diarrhoea, Drug Ineffective, Neoplasm Progression, Multiple Myeloma

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 160 gm;qm;po ; 160 mg;qm;po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-10-18
    End date: 2010-11-09

Dexamethasone
    Dosage: 160 gm;qm;po ; 160 mg;qm;po
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Doxorubicin HCL
    Dosage: 64 mg;qm;iv ; 64 mg;qm;iv
    Indication: Multiple Myeloma
    Start date: 2010-09-27
    End date: 2010-10-17

Doxorubicin HCL
    Dosage: 64 mg;qm;iv ; 64 mg;qm;iv
    Indication: Multiple Myeloma
    Start date: 2010-10-18
    End date: 2010-11-09

Velcade
    Dosage: iv ; iv
    Indication: Multiple Myeloma
    Start date: 2010-09-27

Velcade
    Dosage: iv ; iv
    Indication: Multiple Myeloma
    Start date: 2010-10-18
    End date: 2010-11-10

Other drugs received by patient: Enoxaparin Sodium; Gabapentin; Amoxicillin; Acetaminophen



Possible Dexamethasone side effects in

Reported by a physician from Japan on 2012-06-29

Patient:

Reactions: Nausea, Anaemia, Febrile Neutropenia, Hyponatraemia, Toxicity To Various Agents, Peripheral Sensory Neuropathy, Haematotoxicity, Hypokalaemia, Fatigue, Diarrhoea, Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Bortezomib
    Dosage: days 1, 4, 8 and 11 (1 mg/ m2 in cohort 1 and 1.3 mg/ m2 in cohort 2)
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: days 1-2, 4-5, 8-9 and 11-12
    Administration route: Oral
    Indication: Multiple Myeloma

Doxorubicin HCL
    Dosage: days 1-4

Doxorubicin HCL
    Dosage: days 1-4
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in female

Reported by a physician from United States on 2012-06-29

Patient: female, weighing 77.0 kg (169.4 pounds)

Reactions: Diarrhoea

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Dexamethasone
    Start date: 2012-05-25

Lenalidomide
    Start date: 2012-05-25

Treanda
    Dosage: days 1-2
    Indication: Multiple Myeloma
    Start date: 2012-05-25
    End date: 2012-05-26

Other drugs received by patient: Oxycodone HCL; Metoprolol Succinate; Potassium Chloride; Amitriptyline HCL; Warfarin Sodium; Senokot; Duloxetime Hydrochloride; Vitacal / 01535001 /; Zolpidem Tartrate; Oxycodone Hydrochloride; Omeprazole; Furosemide; Calcium Acetate; Allopurinol; Pamidronate Disodium; Acetylsalicylic Acid SRT; Acyclovir; Bactrim; Phenoxymethyl Penicillin



Possible Dexamethasone side effects in

Reported by a physician from United States on 2012-06-28

Patient:

Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Vomiting, Stomatitis, Dyspnoea, Gastrointestinal Toxicity, Nausea, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Respiratory Failure, Diarrhoea, Neurological Symptom, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: days 1-5 during cycle 3,5 and 7

Cyclophosphamide
    Dosage: days 1-5 during cycle 3,5 and 7

Cyclophosphamide
    Dosage: for 5 days in cycle 1
    Indication: Burkitt's Leukaemia

Cyclophosphamide
    Dosage: for 5 days in cycle 1
    Indication: Burkitt's Lymphoma

Cytarabine
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Cytarabine
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Dexamethasone
    Dosage: on days 1-5 of cycle 2,4 and 6

Dexamethasone
    Dosage: on days 1-5 of cycle 2,4 and 6

Dexamethasone
    Dosage: on days 1-5 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Dexamethasone
    Dosage: on days 1-5 of cycle 3,5 and 7
    Indication: Burkitt's Leukaemia

Doxorubicin HCL
    Dosage: on days 4 and 5 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Dosage: on days 4 and 5 of cycle 3,5 and 7
    Indication: Burkitt's Leukaemia

Etoposide
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Etoposide
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Ifosfamide
    Dosage: on days 1-5 in cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Ifosfamide
    Dosage: on days 1-5 in cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Methotrexate
    Dosage: on day 1 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Methotrexate
    Dosage: on day 1 of cycle 2,4 and 6

Methotrexate
    Dosage: on day 1 of cycle 3,5 and 7

Methotrexate
    Dosage: on day 1 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Prednisone TAB
    Dosage: for 7 days in cycle 1
    Indication: Burkitt's Leukaemia

Prednisone TAB
    Dosage: for 7 days in cycle 1
    Indication: Burkitt's Lymphoma

Rituximab
    Dosage: on day 8 from cycle 3 to 7

Rituximab
    Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
    Indication: Burkitt's Leukaemia

Rituximab
    Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
    Indication: Burkitt's Lymphoma

Rituximab
    Dosage: on day 8 from cycle 3 to 7

Vincristine
    Dosage: on day 1 of cycle 2,4 and 6

Vincristine
    Dosage: on day 1 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Vincristine
    Dosage: on day 1 of cycle 3,5 and 7

Vincristine
    Dosage: on day 1 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Other drugs received by patient: Unknown Medication; Leucovorin Calcium; Filgrastim



Possible Dexamethasone side effects in

Reported by a physician from Japan on 2012-06-28

Patient:

Reactions: Nausea, Anaemia, Febrile Neutropenia, Hyponatraemia, Toxicity To Various Agents, Peripheral Sensory Neuropathy, Haematotoxicity, Hypokalaemia, Fatigue, Diarrhoea, Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Bortezomib
    Dosage: days 1, 4, 8 and 11 (1 mg/ m2 in cohort 1 and 1.3 mg/ m2 in cohort 2)
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: days 1-2, 4-5, 8-9 and 11-12
    Administration route: Oral
    Indication: Multiple Myeloma

Doxorubicin HCL
    Dosage: days 1-4

Doxorubicin HCL
    Dosage: days 1-4
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in

Reported by a physician from Japan on 2012-06-27

Patient:

Reactions: Nausea, Anaemia, Febrile Neutropenia, Hyponatraemia, Toxicity To Various Agents, Peripheral Sensory Neuropathy, Haematotoxicity, Hypokalaemia, Fatigue, Diarrhoea, Neutropenia, Thrombocytopenia

Drug(s) suspected as cause:
Bortezomib
    Dosage: days 1, 4, 8 and 11 (1 mg/ m2 in cohort 1 and 1.3 mg/ m2 in cohort 2)
    Indication: Multiple Myeloma

Dexamethasone
    Dosage: days 1-2, 4-5, 8-9 and 11-12
    Administration route: Oral
    Indication: Multiple Myeloma

Doxorubicin HCL
    Dosage: days 1-4
    Indication: Multiple Myeloma



Possible Dexamethasone side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-25

Patient:

Reactions: Fatigue, Central Nervous System Haemorrhage, Erythema Multiforme, Stomatitis, Vomiting, Dyspnoea, Nausea, Gastrointestinal Toxicity, Condition Aggravated, Rash, Haematotoxicity, Pulmonary Haemorrhage, Tumour Lysis Syndrome, Diarrhoea, Respiratory Failure, Neurological Symptom, Infection

Adverse event resulted in: death

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: for 5 days in cycle 1
    Indication: Burkitt's Lymphoma

Cyclophosphamide
    Dosage: days 1-5 during cycle 3,5 and 7

Cyclophosphamide
    Dosage: days 1-5 during cycle 3,5 and 7

Cyclophosphamide
    Dosage: for 5 days in cycle 1
    Indication: Burkitt's Leukaemia

Cytarabine
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Cytarabine
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Dexamethasone
    Dosage: on days 1-5 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Dexamethasone
    Dosage: on days 1-5 of cycle 2,4 and 6

Dexamethasone
    Dosage: on days 1-5 of cycle 3,5 and 7
    Indication: Burkitt's Leukaemia

Dexamethasone
    Dosage: on days 1-5 of cycle 2,4 and 6

Doxorubicin HCL
    Dosage: on days 4 and 5 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Doxorubicin HCL
    Dosage: on days 4 and 5 of cycle 3,5 and 7
    Indication: Burkitt's Leukaemia

Etoposide
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Etoposide
    Dosage: on days 4 and 5 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Ifosfamide
    Dosage: on days 1-5 in cycle 2,4 and 6
    Indication: Burkitt's Lymphoma

Ifosfamide
    Dosage: on days 1-5 in cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Methotrexate
    Dosage: on day 1 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Methotrexate
    Dosage: on day 1 of cycle 3,5 and 7

Methotrexate
    Dosage: on day 1 of cycle 2,4 and 6

Methotrexate
    Dosage: on day 1 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Prednisone TAB
    Dosage: for 7 days in cycle 1
    Indication: Burkitt's Lymphoma

Prednisone TAB
    Dosage: for 7 days in cycle 1
    Indication: Burkitt's Leukaemia

Rituximab
    Dosage: on day 8 from cycle 3 to 7

Rituximab
    Dosage: on day 8 from cycle 3 to 7

Rituximab
    Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
    Indication: Burkitt's Leukaemia

Rituximab
    Dosage: day 8 on cycle 2; doage increased to 375 mg/m2 on day 10 and 12
    Indication: Burkitt's Lymphoma

Vincristine
    Dosage: on day 1 of cycle 2,4 and 6
    Indication: Burkitt's Leukaemia

Vincristine
    Dosage: on day 1 of cycle 2,4 and 6

Vincristine
    Dosage: on day 1 of cycle 3,5 and 7

Vincristine
    Dosage: on day 1 of cycle 3,5 and 7
    Indication: Burkitt's Lymphoma

Other drugs received by patient: Unknown Medication; Leucovorin Calcium; Filgrastim



Possible Dexamethasone side effects in 64 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-22

Patient: 64 year old male

Reactions: Diarrhoea, Electrolyte Imbalance

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Bendamustine Hydrochloride
    Indication: Multiple Myeloma
    Start date: 2011-09-28
    End date: 2012-05-09

Bendamustine Hydrochloride

Dexamethasone
    Indication: Multiple Myeloma

Thalidomide
    Indication: Multiple Myeloma

Other drugs received by patient: Fluconazole; Cotrim; Lansoprazole; Acyclovir; Ondansetron



Possible Dexamethasone side effects in female

Reported by a physician from United States on 2012-06-21

Patient: female, weighing 50.4 kg (110.9 pounds)

Reactions: Abdominal Pain Lower, Vomiting, Diarrhoea, Nausea, Sepsis, Ventricular Tachycardia

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Dexamethasone

Revlimid
    Dosage: 25 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2012-01-24
    End date: 2012-03-13

Other drugs received by patient: Benazepril Hydrochloride; Ferrous Fumarate; Simvastatin; Amlodipine; Iron; Calcium; Aspirin; Cytoxan



Possible Dexamethasone side effects in 64 year old male

Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-20

Patient: 64 year old male

Reactions: Diarrhoea, Electrolyte Imbalance, Blood Magnesium Decreased, Hypokalaemia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Bendamustine Hydrochloride
    Dosage: 100 mg/m2;iv 50 mg/m2;iv
    Indication: Multiple Myeloma
    Start date: 2011-09-28
    End date: 2012-05-09

Dexamethasone
    Indication: Multiple Myeloma

Thalidomide
    Indication: Multiple Myeloma

Other drugs received by patient: Acyclovir; Ondansetron; Cotrim; Fluconazole; Lansoprazole



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012